At close: January 6 at 4:00:01 PM EST
After hours: 7:11:51 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-55,725.00
-95,141.00
-161,850.00
-142,157.00
-135,108.00
Investing Cash Flow
6,323.00
-131,498.00
-128,238.00
15,804.00
-6,856.00
Financing Cash Flow
-4,913.00
32,485.00
88,027.00
359,668.00
300,589.00
End Cash Position
98,174.00
112,447.00
306,239.00
507,734.00
274,348.00
Income Tax Paid Supplemental Data
1,215.00
1,434.00
3,542.00
118.00
--
Interest Paid Supplemental Data
25,230.00
22,139.00
--
900.00
--
Capital Expenditure
-1,003.00
-2,168.00
-1,351.00
-2,385.00
-514.00
Issuance of Capital Stock
154.00
342.00
190.00
50,060.00
93,279.00
Issuance of Debt
--
300,000.00
73,072.00
293,874.00
119,867.00
Repayment of Debt
-2,513.00
-241,617.00
--
--
-52,420.00
Free Cash Flow
-56,728.00
-97,309.00
-163,201.00
-144,542.00
-135,622.00
12/31/2020 - 3/4/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AUPH Aurinia Pharmaceuticals Inc.
8.38
-1.87%
AGEN Agenus Inc.
3.3100
+1.22%
INCY Incyte Corporation
71.91
+3.27%
EXEL Exelixis, Inc.
33.20
-2.27%
PHAT Phathom Pharmaceuticals, Inc.
7.61
-1.68%
IOVA Iovance Biotherapeutics, Inc.
7.48
-2.22%
RIGL Rigel Pharmaceuticals, Inc.
16.60
-4.49%
ACAD ACADIA Pharmaceuticals Inc.
17.46
-5.16%
ANVS Annovis Bio, Inc.
5.35
-0.74%
LXRX Lexicon Pharmaceuticals, Inc.
0.9143
+15.94%